Source: International Congress 2018 – Eosinophils in airway disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Soe (Moscow, Russian Federation), M. Kevorkova (Moscow, Russian Federation), G. Nuralieva (Moscow, Russian Federation), A. Belevskiy (Moscow, Russian Federation), S. Avdeev (Moscow, Russian Federation), A. Chuchalin (Moscow, Russian Federation). Blood eosinophilia(BE) and outcomes in patients with acute severe exacerbations of COPD(AECOPD). 5382

Member's Comments

No comment yet.

Related content which might interest you: COPD patients admitted in ICU for acute exacerbation: Impact of exacerbation factors on prognosis Source: International Congress 2016 – Dealing with the complexity of critically-ill patients Year: 2016 Sit-to-stand ability in patients hospitalised for acute exacerbation of COPD: Clinical characteristics and short-term outcomes Source: International Congress 2015 – New insights into exercise and muscle performance Year: 2015 Co-morbidity and hospitalization rate in patients (pts) with acute exacerbation (AE) of COPD Source: International Congress 2015 – Different data in COPD Year: 2015 Severe outcomes of COVID-19 among patients with COPD and asthma Source: ERJ Open Res, 7 (1) 00594-2020; 10.1183/23120541.00594-2020 Year: 2021 Hyperglycemia is associated with poor outcomes in patients with acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2013 –COPD biomarkers Year: 2013 High urea levels predict long term mortality in patients hospitalised for acute exacerbation of COPD Source: International Congress 2014 – ICU outcomes, sepsis and infections Year: 2014 Predictors of poor outcome in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) receiving noninvasive positive pressure ventilation (NPPV Source: International Congress 2015 – Outcome of noninvasive ventilatory support in acute and chronic respiratory failure Year: 2015 Characteristics and outcomes of hospitalizations for acute exacerbation of chronic obstructive pulmonary disease (AECOPD) Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease Year: 2012 Vascular-platelet hemostasis parameters in the stable phase and in acute exacerbation (AE) of COPD Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction Year: 2015 Influence of previous admissions on audit outcomes in patients admitted with acute exacerbation of COPD (AECOPD) Source: International Congress 2017 – What is new in COPD diagnosis and classification? Year: 2017 One year experience with acute COPD assessment service (ACAS) for patients with acute exacerbations of COPD Source: Eur Respir J 2006; 28: Suppl. 50, 178s Year: 2006 Predictors of severe exacerbations in patients with moderate and severe asthma Source: International Congress 2018 – Determinants and monitoring of asthma control Year: 2018 Risk of myocardial infarction (MI) associated with acute exacerbations of COPD (AECOPD): Effects of exacerbation frequency Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD Year: 2016 Quantification of severity of the acute exacerbation in hospitalized COPD patients Source: Eur Respir J 2003; 22: Suppl. 45, 559s Year: 2003 Determinants of 6-months mortality in elderly patients admitted for non-acidotic acute exacerbation of COPD (AECOPD) Source: Annual Congress 2007 - COPD and comorbidity Year: 2007 Surfactant protein D (SPD) like marker of effectiveness in patients (pts) with acute exacerbations (AE) of COPD ofphosphatidylcholine treatment outcomes Source: International Congress 2015 – Different data in COPD Year: 2015 Early readmission after hospitalization for acute exacerbations of chronic obstructive pulmonary disease (AECOPD) is associated with high mortality Source: Annual Congress 2013 –COPD diagnosis Year: 2013 Outcome of patients following hospitalization with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) , with and without cardiovascular risk factors Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 Impact of moderate and severe exacerbations in severe COPD patients Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 Acute exacerbation of COPD (AECOPD) during pulmonary rehabilitation (PR): impact on outcomes and short-term prediction of risk. Source: International Congress 2017 – Latest insights into chronic care Year: 2017